TY  - RPRT
TI  - A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
AU  - Keshwar Baboolal
PY  - 2003
DO  - 10.1097/01.tp.0000063703.32564.3b
UR  - https://pubmed.ncbi.nlm.nih.gov/12717239/
ID  - 12717239
ER  -